This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Kee Song Bio-Technology Holdings Crescita futura

Future criteri di controllo 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Kee Song Bio-Technology Holdings.

Informazioni chiave

n/a

Tasso di crescita degli utili

n/a

Tasso di crescita dell'EPS

Food crescita degli utili	17.0%
Tasso di crescita dei ricavi	n/a
Rendimento futuro del capitale proprio	n/a
Copertura analitica	None
Ultimo aggiornamento	n/a

Aggiornamenti recenti sulla crescita futura

Nessun aggiornamento

Recent updates

Health Check: How Prudently Does Kee Song Bio-Technology Holdings (GTSM:1258) Use Debt?

Mar 15

Health Check: How Prudently Does Kee Song Bio-Technology Holdings (GTSM:1258) Use Debt?

Nov 30

In questa sezione di solito presentiamo le proiezioni di crescita dei ricavi e degli utili basate sulle stime di consenso degli analisti professionisti per aiutare gli investitori a capire la capacità della società di generare profitti. Tuttavia, poiché Kee Song Bio-Technology Holdings non ha fornito dati sufficienti sul passato e non ha previsioni degli analisti, i suoi utili futuri non possono essere calcolati in modo affidabile estrapolando i dati passati o utilizzando le previsioni degli analisti.

Si tratta di una situazione piuttosto rara, dato che il 97% delle società coperte da SimplyWall St dispone di dati finanziari passati.

Previsioni di crescita degli utili e dei ricavi

TPEX:1258 - Stime future degli analisti e dati finanziari passati (TWD Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
3/31/2023	2,698	130	269	321	N/A
12/31/2022	2,571	95	204	254	N/A
9/30/2022	2,446	61	167	200	N/A
6/30/2022	2,406	99	254	291	N/A
3/31/2022	2,318	76	204	233	N/A
12/31/2021	2,289	74	203	228	N/A
9/30/2021	2,267	12	166	199	N/A
6/30/2021	2,331	48	146	178	N/A
3/31/2021	2,401	57	150	184	N/A
12/31/2020	2,545	-16	119	158	N/A
9/30/2020	2,721	-56	72	90	N/A
6/30/2020	2,913	-90	-54	5	N/A
3/31/2020	2,978	-167	-170	-17	N/A
12/31/2019	3,039	-125	-237	-67	N/A
9/30/2019	3,005	-97	-310	3	N/A
6/30/2019	2,907	-216	-365	-13	N/A
3/31/2019	2,940	-170	-400	29	N/A
12/31/2018	2,835	-149	-468	74	N/A
9/30/2018	2,702	-124	-523	15	N/A
6/30/2018	2,662	9	-381	53	N/A
3/31/2018	2,553	26	-258	78	N/A
12/31/2017	2,481	46	-662	89	N/A
9/30/2017	2,467	68	-663	90	N/A
6/30/2017	2,448	107	-703	102	N/A
3/31/2017	2,433	122	-677	85	N/A
12/31/2016	2,436	136	N/A	123	N/A
9/30/2016	2,391	142	N/A	317	N/A
6/30/2016	2,302	141	N/A	326	N/A
3/31/2016	2,121	139	N/A	262	N/A
12/31/2015	1,837	129	N/A	244	N/A
9/30/2015	1,644	134	N/A	123	N/A
6/30/2015	1,416	105	N/A	111	N/A
3/31/2015	1,304	99	N/A	149	N/A
12/31/2014	1,309	93	N/A	134	N/A
9/30/2014	1,289	88	N/A	122	N/A
6/30/2014	1,278	84	N/A	130	N/A
3/31/2014	1,264	71	N/A	102	N/A
12/31/2013	1,259	58	N/A	77	N/A
9/30/2013	1,278	50	N/A	-17	N/A
6/30/2013	1,299	53	N/A	41	N/A
3/31/2013	1,323	67	N/A	88	N/A
12/31/2012	1,343	88	N/A	128	N/A
9/30/2012	1,338	92	N/A	118	N/A
6/30/2012	1,329	96	N/A	133	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Insufficient data to determine if 1258's forecast earnings growth is above the savings rate (0.8%).

Guadagni vs Mercato: Insufficient data to determine if 1258's earnings are forecast to grow faster than the TW market

Guadagni ad alta crescita: Insufficient data to determine if 1258's earnings are expected to grow significantly over the next 3 years.

Ricavi vs Mercato: Insufficient data to determine if 1258's revenue is forecast to grow faster than the TW market.

Ricavi ad alta crescita: Insufficient data to determine if 1258's revenue is forecast to grow faster than 20% per year.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Insufficient data to determine if 1258's Return on Equity is forecast to be high in 3 years time

This company listing is no longer active

Kee Song Bio-Technology Holdings Crescita futura

Future criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Recent updates

First quarter 2023 earnings released: EPS: NT$1.46 (vs NT$0.51 in 1Q 2022)

Full year 2022 earnings released: EPS: NT$2.57 (vs NT$2.00 in FY 2021)

Third quarter 2022 earnings released: NT$1.29 loss per share (vs NT$0.25 loss in 3Q 2021)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: NT$1.30 (vs NT$0.67 in 2Q 2021)

Kee Song Bio-Technology Holdings Limited Announces Directors Elections

Kee Song Bio-Technology Holdings Limited Announces General Manager Changes

Kee Song Bio-Technology Holdings Limited Announces Board Changes

Investor sentiment deteriorated over the past week

First quarter 2022 earnings released: EPS: NT$0.51 (vs NT$0.45 in 1Q 2021)

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: NT$0.24 loss per share (vs NT$0.74 profit in 3Q 2020)

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS NT$0.66 (vs NT$0.92 in 2Q 2020)

First quarter 2021 earnings released: EPS NT$0.45 (vs NT$1.54 loss in 1Q 2020)

Full year 2020 earnings released: NT$0.43 loss per share (vs NT$3.39 loss in FY 2019)

Health Check: How Prudently Does Kee Song Bio-Technology Holdings (GTSM:1258) Use Debt?

New 90-day high: NT$18.25

Health Check: How Prudently Does Kee Song Bio-Technology Holdings (GTSM:1258) Use Debt?

Third quarter 2020 earnings released: EPS NT$0.74

New 90-day high: NT$14.90

First half earnings released

New 90-day high - NT$13.85

First half earnings released

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita